PharmaCyte Biotech, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
30 April
PharmaCyte Biotech, Inc. has filed 470 SEC EDGAR filings since 20 Aug 2001

SEC filing history

Showing 201-225 of 390 matching filings.

Per page
25
Current page
9
8-K File 333-68008

FORM 8-K

Filing date
04 Jun 2021
Reporting date
04 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
06 May 2021
Reporting date
05 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-255044

EFFECT filing

Filing date
14 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-255044

FORM S-3 REGISTRATION STATEMENT

Filing date
05 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-68008

QUARTERLY REPORT

Filing date
11 Dec 2020
Reporting date
31 Oct 2020
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
16 Oct 2020
Reporting date
14 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-68008

QUARTERLY REPORT

Filing date
11 Sep 2020
Reporting date
31 Jul 2020
Next action
Verify source filing
SC 13D/A File 005-91495

SC 13D/A

Filing date
29 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 333-68008

EXTENSION

Filing date
29 Jul 2020
Reporting date
30 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91495

SC 13D

Filing date
06 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
08 Apr 2020
Reporting date
06 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
21 Jan 2020
Reporting date
21 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 333-68008

EXTENSION

Filing date
16 Dec 2019
Reporting date
31 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
08 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
03 Oct 2019
Reporting date
20 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
26 Aug 2019
Reporting date
23 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 333-68008

NOTICE OF LATE FILING

Filing date
29 Jul 2019
Reporting date
30 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .